rivastigmine has been researched along with Behavior Disorders in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 13 (68.42) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cumbo, E; Ligori, LD | 1 |
| Matsuda, T | 1 |
| Morgan, S; Rodda, J; Walker, Z | 1 |
| Freedman, M; Kaye, ED; Petrovic-Poljak, A; Verhoeff, NP | 1 |
| Deuschl, G; Förstl, H; Mollenhauer, B; Oertel, W; Storch, A; Trenkwalder, C | 1 |
| Landau, R | 1 |
| Gabelli, C | 1 |
| Finkel, SI | 1 |
| Morgan, J; Sethi, KD | 1 |
| Grossberg, GT | 1 |
| Cummings, JL | 1 |
| Beusterien, KM; Musher, J; Narayanan, S; Strunk, B; Thomas, SK | 1 |
| Hughes, TL; Iraqi, A | 1 |
| Campanozzi, MD; Casali, E; Martini, E; Neri, M; Neviani, F | 1 |
| Gruber, J; Hollenack, K; O'Shea, T; Stefanacci, R; Tangalos, EG; Zarowitz, BJ | 1 |
| Figiel, G; Sadowsky, C | 1 |
| Lacomblez, L | 1 |
10 review(s) available for rivastigmine and Behavior Disorders
| Article | Year |
|---|---|
Psychopharmacological Studies in Mice.
Topics: Alzheimer Disease; Animals; Cholinesterase Inhibitors; Disease Models, Animal; Donepezil; Dopamine; Drug Discovery; Environment; Female; Galantamine; Indans; Male; Mental Disorders; Mice; Molecular Targeted Therapy; Motivation; Piperidines; Psychopharmacology; Rats; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT1D; Receptors, Dopamine D2; Research; Rivastigmine | 2016 |
Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.
Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Evidence-Based Medicine; Galantamine; Humans; Indans; Mental Disorders; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome | 2009 |
Frontotemporal dementia and pharmacologic interventions.
Topics: Antidepressive Agents; Brain; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Corpus Striatum; Dopamine; Frontotemporal Dementia; Galantamine; Humans; Mental Disorders; Neuroprotective Agents; Phenylcarbamates; Receptors, Serotonin; Rivastigmine; Selegiline | 2010 |
Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions.
Topics: Aged; Brain; Cholinesterase Inhibitors; Cross-Sectional Studies; Dementia; Diagnosis, Differential; Diagnostic Imaging; Donepezil; Early Diagnosis; Humans; Indans; Lewy Body Disease; Mental Disorders; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine | 2010 |
Rivastigmine: an update on therapeutic efficacy in Alzheimer's disease and other conditions.
Topics: Activities of Daily Living; Alzheimer Disease; Carbamates; Cognition; Disease Progression; Economics, Pharmaceutical; Humans; Mental Disorders; Meta-Analysis as Topic; Neuroprotective Agents; Phenylcarbamates; Risk Factors; Rivastigmine; Treatment Outcome | 2003 |
Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's disease.
Topics: Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Humans; Mental Disorders; Meta-Analysis as Topic; Neuroprotective Agents; Phenylcarbamates; Rivastigmine; Severity of Illness Index; Treatment Outcome | 2004 |
Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's disease.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Humans; Mental Disorders; Meta-Analysis as Topic; Neuroprotective Agents; Phenylcarbamates; Rivastigmine | 2005 |
The application of evidence-based principles of care in older persons (issue 5): Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Evidence-Based Medicine; Geriatric Assessment; Humans; Indans; Mental Disorders; Nootropic Agents; Phenylcarbamates; Piperidines; Positron-Emission Tomography; Rivastigmine; Tacrine | 2007 |
A systematic review of the effectiveness of rivastigmine for the treatment of behavioral disturbances in dementia and other neurological disorders.
Topics: Acetylcholine; Cholinergic Fibers; Dementia; Humans; Mental Disorders; Nervous System Diseases; Neuroprotective Agents; Phenylcarbamates; Rivastigmine; Treatment Outcome | 2008 |
Understanding changes in cholinergic function: implications for treating dementia.
Topics: Activities of Daily Living; Alzheimer Disease; Carbamates; Cholinergic Fibers; Cholinesterase Inhibitors; Dementia; Humans; Lewy Body Disease; Mental Disorders; Neuroprotective Agents; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Rivastigmine; Severity of Illness Index; Treatment Outcome | 2002 |
2 trial(s) available for rivastigmine and Behavior Disorders
| Article | Year |
|---|---|
Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Behavioral Symptoms; Cholinesterase Inhibitors; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Female; Galantamine; Humans; Indans; Longitudinal Studies; Male; Memantine; Mental Disorders; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Rivastigmine | 2014 |
Rivastigmine for dementia associated with Parkinson's disease.
Topics: Aged; Cholinesterase Inhibitors; Dementia; Dose-Response Relationship, Drug; Female; Humans; Male; Mental Disorders; Middle Aged; Nausea; Neuroprotective Agents; Parkinson Disease; Patient Selection; Phenylcarbamates; Prospective Studies; Rivastigmine; Treatment Outcome; Tremor; Vomiting | 2005 |
7 other study(ies) available for rivastigmine and Behavior Disorders
| Article | Year |
|---|---|
Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions: Evidence is not satisfactory.
Topics: Aged; Brain; Cholinesterase Inhibitors; Cross-Sectional Studies; Dementia; Diagnosis, Differential; Diagnostic Imaging; Donepezil; Early Diagnosis; Evidence-Based Medicine; Humans; Indans; Lewy Body Disease; Mental Disorders; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine | 2011 |
Behavioral and neuropsychiatric outcomes in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Diagnostic and Statistical Manual of Mental Disorders; Galantamine; Humans; Mental Disorders; Phenylcarbamates; Prevalence; Rivastigmine | 2005 |
Antipsychotic drug use among nursing home residents taking rivastigmine.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Antipsychotic Agents; Chi-Square Distribution; Cholinesterase Inhibitors; Drug Utilization Review; Female; Geriatric Assessment; Grief; Humans; Male; Mental Disorders; Nursing Homes; Phenylcarbamates; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Rivastigmine; Sleep Wake Disorders; Stress, Psychological; Surveys and Questionnaires; Treatment Outcome; United States | 2006 |
Antipsychotic drug use among nursing home residents taking rivastigmine.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Cholinesterase Inhibitors; Drug Therapy, Combination; Drug Utilization; Humans; Mental Disorders; Nursing Homes; Patient Selection; Phenylcarbamates; Research Design; Rivastigmine; Severity of Illness Index | 2006 |
Evaluation of the slopes of cognitive impairment and disability in Alzheimer's disease (AD) patients treated with acetylcholinesterase inhibitors (AChEl).
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Disability Evaluation; Donepezil; Female; Follow-Up Studies; Galantamine; Humans; Indans; Male; Mental Disorders; Neuropsychological Tests; Phenylcarbamates; Piperidines; Rivastigmine; Severity of Illness Index | 2007 |
[Drug therapy strategies in Alzheimer's disease].
Topics: Aggression; Alzheimer Disease; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition Disorders; Depression; Donepezil; Humans; Indans; Mental Disorders; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Sleep Wake Disorders; Tacrine | 1998 |
New insights into genetics and pathophysiology of Alzheimer's disease: what are the clinical and therapeutic implications?
Topics: Acetylcholinesterase; Alzheimer Disease; Brain; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Humans; Mental Disorders; Parasympathetic Nervous System; Phenylcarbamates; Rivastigmine | 2000 |